Chinese General Practice ›› 2023, Vol. 26 ›› Issue (18): 2203-2208.DOI: 10.12114/j.issn.1007-9572.2022.0884
Special Issue: 胰腺炎最新文章合集; 肥胖最新文章合集
• Original Research • Previous Articles Next Articles
Received:
2022-12-07
Revised:
2023-02-16
Published:
2023-06-20
Online:
2023-02-27
Contact:
JIANG Xiaozhong
通讯作者:
蒋晓忠
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0884
组别 | 例数 | 性别(男/女) | 年龄(岁) | BMI (kg/m2) | SBP (mm Hg) | DBP (mm Hg) | TG (mmol/L) | TC (mmol/L) | HDL-C (mmol/L) |
---|---|---|---|---|---|---|---|---|---|
Q1组 | 25 929 | 19 303/6 626 | 50.6±14.2 | 23.4±2.6 | 125±20 | 81±11 | 1.39±1.02 | 4.72±1.06 | 1.54±0.39 |
Q2组 | 25 797 | 19 706/6 091 | 49.5±13.3 | 23.6±2.5 | 126±19 | 81±11 | 1.44±1.05 | 4.83±1.01 | 1.52±0.36 |
Q3组 | 25 162 | 20 213/4 949 | 50.4±12.6 | 23.9±2.3 | 128±19 | 83±11 | 1.52±1.12 | 4.95±1.03 | 1.50±0.36 |
Q4组 | 25 624 | 21 991/3 633 | 53.7±11.6 | 24.4±2.3 | 134±20 | 85±11 | 1.78±1.33 | 5.11±1.12 | 1.52±0.37 |
F(χ2)值 | 1 182.09a | 521.12 | 762.17 | 957.57 | 670.85 | 616.09 | 617.86 | 50.84 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
组别 | LDL-C (mmol/L) | 吸烟史〔n(%)〕 | 饮酒史〔n(%)〕 | 受教育年限≥9年〔n(%)〕 | 体育锻炼≥3次/周〔n(%)〕 | 高血压病史〔n(%)〕 | 糖尿病病史〔n(%)〕 | 胆石症病史〔n(%)〕 | |
Q1组 | 2.17±0.86 | 8 927(34.43) | 1 797(6.93) | 6 801(26.23) | 5 624(21.69) | 12 169(46.93) | 3 835(14.79) | 819(3.16) | |
Q2组 | 2.34±0.80 | 8 582(33.27) | 1 878(7.28) | 6 738(26.12) | 4 889(18.95) | 12 487(48.40) | 4 715(18.28) | 703(2.73) | |
Q3组 | 2.45±0.81 | 9 133(36.30) | 2 041(8.11) | 6 391(25.40) | 4 898(19.47) | 13 314(52.91) | 5 253(20.88) | 745(2.96) | |
Q4组 | 2.52±0.85 | 9 623(37.55) | 2 426(9.47) | 4 990(19.47) | 5 494(21.44) | 15 794(61.64) | 11 523(44.97) | 911(3.56) | |
F(χ2)值 | 870.78 | 122.88a | 134.32a | 439.74a | 90.53a | 1 355.22a | 7 798.12a | 31.67a | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of baseline information of non-obese population in different FPG level groups
组别 | 例数 | 性别(男/女) | 年龄(岁) | BMI (kg/m2) | SBP (mm Hg) | DBP (mm Hg) | TG (mmol/L) | TC (mmol/L) | HDL-C (mmol/L) |
---|---|---|---|---|---|---|---|---|---|
Q1组 | 25 929 | 19 303/6 626 | 50.6±14.2 | 23.4±2.6 | 125±20 | 81±11 | 1.39±1.02 | 4.72±1.06 | 1.54±0.39 |
Q2组 | 25 797 | 19 706/6 091 | 49.5±13.3 | 23.6±2.5 | 126±19 | 81±11 | 1.44±1.05 | 4.83±1.01 | 1.52±0.36 |
Q3组 | 25 162 | 20 213/4 949 | 50.4±12.6 | 23.9±2.3 | 128±19 | 83±11 | 1.52±1.12 | 4.95±1.03 | 1.50±0.36 |
Q4组 | 25 624 | 21 991/3 633 | 53.7±11.6 | 24.4±2.3 | 134±20 | 85±11 | 1.78±1.33 | 5.11±1.12 | 1.52±0.37 |
F(χ2)值 | 1 182.09a | 521.12 | 762.17 | 957.57 | 670.85 | 616.09 | 617.86 | 50.84 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
组别 | LDL-C (mmol/L) | 吸烟史〔n(%)〕 | 饮酒史〔n(%)〕 | 受教育年限≥9年〔n(%)〕 | 体育锻炼≥3次/周〔n(%)〕 | 高血压病史〔n(%)〕 | 糖尿病病史〔n(%)〕 | 胆石症病史〔n(%)〕 | |
Q1组 | 2.17±0.86 | 8 927(34.43) | 1 797(6.93) | 6 801(26.23) | 5 624(21.69) | 12 169(46.93) | 3 835(14.79) | 819(3.16) | |
Q2组 | 2.34±0.80 | 8 582(33.27) | 1 878(7.28) | 6 738(26.12) | 4 889(18.95) | 12 487(48.40) | 4 715(18.28) | 703(2.73) | |
Q3组 | 2.45±0.81 | 9 133(36.30) | 2 041(8.11) | 6 391(25.40) | 4 898(19.47) | 13 314(52.91) | 5 253(20.88) | 745(2.96) | |
Q4组 | 2.52±0.85 | 9 623(37.55) | 2 426(9.47) | 4 990(19.47) | 5 494(21.44) | 15 794(61.64) | 11 523(44.97) | 911(3.56) | |
F(χ2)值 | 870.78 | 122.88a | 134.32a | 439.74a | 90.53a | 1 355.22a | 7 798.12a | 31.67a | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
自变量 | β | SE | Wald χ2值 | P值 | HR值 | 95%CI |
---|---|---|---|---|---|---|
性别(男) | 0.28 | 0.17 | 2.78 | 0.096 | 1.32 | (0.95,1.82) |
年龄 | 0.02 | 0.01 | 10.66 | 0.001 | 1.02 | (1.01,1.03) |
TG | 0.19 | 0.04 | 29.89 | <0.001 | 1.22 | (1.13,1.30) |
TC | 0.07 | 0.05 | 1.82 | 0.177 | 1.07 | (0.97,1.18) |
HDL-C | 0.11 | 0.15 | 0.49 | 0.483 | 1.11 | (0.83,1.50) |
吸烟史 | -0.03 | 0.13 | 0.07 | 0.793 | 0.97 | (0.75,1.25) |
饮酒史 | 0.08 | 0.20 | 0.17 | 0.678 | 1.09 | (0.73,1.62) |
受教育年限≥9年 | -0.43 | 0.16 | 6.82 | 0.009 | 0.65 | (0.47,0.90) |
体育锻炼≥3次/周 | 0.11 | 0.14 | 0.62 | 0.430 | 1.12 | (0.85,1.47) |
高血压病史 | -0.12 | 0.12 | 1.05 | 0.306 | 0.89 | (0.71,1.12) |
胆石症病史 | 1.03 | 0.20 | 26.19 | <0.001 | 2.79 | (1.88,4.13) |
Table 2 Cox proportional hazards models for new-onset AP in non-obese population
自变量 | β | SE | Wald χ2值 | P值 | HR值 | 95%CI |
---|---|---|---|---|---|---|
性别(男) | 0.28 | 0.17 | 2.78 | 0.096 | 1.32 | (0.95,1.82) |
年龄 | 0.02 | 0.01 | 10.66 | 0.001 | 1.02 | (1.01,1.03) |
TG | 0.19 | 0.04 | 29.89 | <0.001 | 1.22 | (1.13,1.30) |
TC | 0.07 | 0.05 | 1.82 | 0.177 | 1.07 | (0.97,1.18) |
HDL-C | 0.11 | 0.15 | 0.49 | 0.483 | 1.11 | (0.83,1.50) |
吸烟史 | -0.03 | 0.13 | 0.07 | 0.793 | 0.97 | (0.75,1.25) |
饮酒史 | 0.08 | 0.20 | 0.17 | 0.678 | 1.09 | (0.73,1.62) |
受教育年限≥9年 | -0.43 | 0.16 | 6.82 | 0.009 | 0.65 | (0.47,0.90) |
体育锻炼≥3次/周 | 0.11 | 0.14 | 0.62 | 0.430 | 1.12 | (0.85,1.47) |
高血压病史 | -0.12 | 0.12 | 1.05 | 0.306 | 0.89 | (0.71,1.12) |
胆石症病史 | 1.03 | 0.20 | 26.19 | <0.001 | 2.79 | (1.88,4.13) |
自变量 | β | SE | Waldχ2值 | P值 | HR值 | 95%CI |
---|---|---|---|---|---|---|
模型1(以Q1组为参照) | ||||||
Q2组 | 0.21 | 0.17 | 1.66 | 0.197 | 1.24 | (0.90,1.71) |
Q3组 | 0.09 | 0.17 | 0.26 | 0.611 | 1.09 | (0.78,1.53) |
Q4组 | 0.52 | 0.16 | 10.79 | 0.001 | 1.68 | (1.23,2.28) |
模型2(以Q1组为参照) | ||||||
Q2组 | 0.24 | 0.17 | 2.01 | 0.156 | 1.27 | (0.91,1.75) |
Q3组 | 0.09 | 0.17 | 0.25 | 0.615 | 1.09 | (0.78,1.53) |
Q4组 | 0.44 | 0.16 | 7.88 | 0.005 | 1.56 | (1.14,2.12) |
模型3(以Q1组为参照) | ||||||
Q2组 | 0.22 | 0.17 | 1.71 | 0.190 | 1.24 | (0.90,1.72) |
Q3组 | 0.05 | 0.17 | 0.10 | 0.781 | 1.05 | (0.75,1.48) |
Q4组 | 0.34 | 0.16 | 4.32 | 0.035 | 1.40 | (1.02,1.92) |
模型4(以Q1组为参照) | ||||||
Q2组 | 0.22 | 0.17 | 1.77 | 0.183 | 1.25 | (0.90,1.73) |
Q3组 | 0.05 | 0.17 | 1.00 | 0.752 | 1.06 | (0.75,1.48) |
Q4组 | 0.33 | 0.16 | 4.32 | 0.038 | 1.40 | (1.02,1.92) |
Table 3 Cox proportional hazards models for new-onset AP among different FPG level groups
自变量 | β | SE | Waldχ2值 | P值 | HR值 | 95%CI |
---|---|---|---|---|---|---|
模型1(以Q1组为参照) | ||||||
Q2组 | 0.21 | 0.17 | 1.66 | 0.197 | 1.24 | (0.90,1.71) |
Q3组 | 0.09 | 0.17 | 0.26 | 0.611 | 1.09 | (0.78,1.53) |
Q4组 | 0.52 | 0.16 | 10.79 | 0.001 | 1.68 | (1.23,2.28) |
模型2(以Q1组为参照) | ||||||
Q2组 | 0.24 | 0.17 | 2.01 | 0.156 | 1.27 | (0.91,1.75) |
Q3组 | 0.09 | 0.17 | 0.25 | 0.615 | 1.09 | (0.78,1.53) |
Q4组 | 0.44 | 0.16 | 7.88 | 0.005 | 1.56 | (1.14,2.12) |
模型3(以Q1组为参照) | ||||||
Q2组 | 0.22 | 0.17 | 1.71 | 0.190 | 1.24 | (0.90,1.72) |
Q3组 | 0.05 | 0.17 | 0.10 | 0.781 | 1.05 | (0.75,1.48) |
Q4组 | 0.34 | 0.16 | 4.32 | 0.035 | 1.40 | (1.02,1.92) |
模型4(以Q1组为参照) | ||||||
Q2组 | 0.22 | 0.17 | 1.77 | 0.183 | 1.25 | (0.90,1.73) |
Q3组 | 0.05 | 0.17 | 1.00 | 0.752 | 1.06 | (0.75,1.48) |
Q4组 | 0.33 | 0.16 | 4.32 | 0.038 | 1.40 | (1.02,1.92) |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编辑委员会,《中华消化杂志》编辑委员会. 中国急性胰腺炎诊治指南(2019,沈阳)[J]. 中华胰腺病杂志,2019,19(5):321-331. DOI:10.3760/cma.j.issn.1674-1935.2019.05.001.
|
[12] |
中国超重/肥胖医学营养治疗专家共识编写委员会. 中国超重/肥胖医学营养治疗专家共识(2016年版)[J]. 中华糖尿病杂志,2016,8(9):525-540. DOI:10.3760/cma.j.issn.1674-5809.2016.09.004.
|
[13] |
苏阿芳,王银洁,王凤飞,等. 非肥胖人群基线三酰甘油水平与急性胰腺炎发病风险关系的前瞻性队列研究[J]. 中国全科医学,2022,25(26):3240-3245. DOI:10.12114/j.issn.1007-9572.2022.0215.
|
[14] |
曹阳,张罗漫. 运用SAS对不完整数据集进行多重填补——SAS 9中的多重填补及其统计分析过程(一)[J]. 中国卫生统计,2004,21(1):56-58,63. DOI:10.3969/j.issn.1002-3674.2004.01.018.
|
[15] |
|
[16] |
王珊,张健,蒋晓忠,等. 非肥胖人群的腰围轨迹与新发非酒精性脂肪肝的相关性[J]. 中华流行病学杂志,2020,41(6):824-828. DOI:10.3760/cma.j.cn112338-20190630-00479.
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
张冰,朱国玲,孙秋,等. 基线空腹血糖水平与急性胰腺炎发病风险的前瞻性队列研究[J]. 中国全科医学,2021,24(1):60-64. DOI:10.12114/j.issn.1007-9572.2020.00.602.
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[1] | ZHANG Yuan, HOU Qiqi, QI Qi, JIANG Yue, WANG Nan, YUE Bocheng, CHEN Shuohua, HAN Quanle, WU Shouling, LI Kangbo. Relationship between Cardiovascular Health Score of Life's Essential 8 and New-onset Atrial Fibrillation: a Large Sample, Long-Term Follow-up Study [J]. Chinese General Practice, 2024, 27(12): 1431-1437. |
[2] | JIN Menglong, QIN Xiaoying, MALIYA Amiti, JIAZINI Nuerbai, LI Jianxin, CAO Jie, LUO Sifu, LIU Cheng, ZHANG Yuchen, GAI Mintao, LI Yanpeng, LU Xiangfeng, FU Zhenyan. Status and Influencing Factors of Dyslipidemia, Hypertension and Diabetes Comorbidities among Kazakhs in Xinjiang [J]. Chinese General Practice, 2024, 27(12): 1438-1444. |
[3] | KANG Jing, ZHANG Ci, ZHANG Zhengyi. Distribution and Influencing Factors of Chronic Comorbidities among Middle-aged Inpatients in General Practice Department of Tertiary General Hospitals [J]. Chinese General Practice, 2024, 27(11): 1310-1315. |
[4] | HE Haiyang, YANG Jialing, LEI Xun. Prevalence and Influencing Factors of Osteoporosis in Postmenopausal Women: a Meta-analysis [J]. Chinese General Practice, 2024, 27(11): 1370-1379. |
[5] | XU Jun, QI Wenjie, WANG Chao, HU Lan, MIAO Bin. Analysis of Clinical Characteristics and Maternal and Neonatal Outcomes in Pregnancy Complicated with Acute Pancreatitis Patients of Different Etiologies [J]. Chinese General Practice, 2024, 27(11): 1343-1348. |
[6] | SHANG Jinmeng, DENG Xiaowei. Characteristics and Risk Factors of Preserved Ratio Impaired Spirometry in Physical Examination Population [J]. Chinese General Practice, 2024, 27(11): 1331-1336. |
[7] | YU Xinyan, SU Peng, YUAN Xiaojing, JIANG Qingru, YANG Jianyun, ZHAO Xudong, WANG Yifan, ZHANG Haicheng. A Study on the Factors Influencing the Comprehensive Risk of Cardiovascular Disease in Elderly Patients with Chronic Disease in Primary Care [J]. Chinese General Practice, 2024, 27(10): 1186-1193. |
[8] | DAI Zhenwei, ZHANG Ling, ZHANG Haoran, XIAO Weijun, WANG Hao, HUANG Yiman, JING Shu, CHEN Xu, FU Jiaqi, WU Yijin, GAO Lei, SU Xiaoyou. Influencing Factors of Blood Glucose Monitoring in Middle-aged and Elderly Patients with Type-2 Diabetes Mellitus in Rural Areas [J]. Chinese General Practice, 2024, 27(10): 1194-1200. |
[9] | CHEN Dan, WANG Yawei, HUANG Fang, XU Yifan, ZHANG Yiying, SHAO Yueqin. Epidemic Trend Analysis of Colorectal Cancer in Jiading District, Shanghai from 2003 to 2019 [J]. Chinese General Practice, 2024, 27(10): 1261-1266. |
[10] | ZHANG Min, LU Yuan, GAO Song, MA Jia, LIU Yalin, ZHAI Jiayi, YU Dehua. Analysis on the Perceptions Toward Mild Cognitive Impairment and Medical Willingness among Population Aged over 55 Years in Shanghai Based on a Proactive Health Perspective [J]. Chinese General Practice, 2024, 27(10): 1208-1214. |
[11] | XIONG Liufang, ZHOU Xiaozhao, MA Hanying, ZHAO Tiefu. Factors Influencing the Demand for Long-term Family Doctor Contract in Community Health Service Centers [J]. Chinese General Practice, 2024, 27(10): 1238-1244. |
[12] | GAO Chuan, LI Qingyin, KE Dandan, ZHOU Yuyu, ZHANG Yuyang, HE Zhong. The Utilization of Health Checkup Services among People Aged 45 and above in China: a National Cross-sectional Survey Based on CHARLS 2018 [J]. Chinese General Practice, 2024, 27(10): 1179-1185. |
[13] | ZHANG Xing, DONG Jing, GUO Yi, XU Jianwei, BAI Yamin, LIU Min, ZHANG Xiaochang, GUO Xiaolei, MA Jixiang, SUN Xinying. Influencing Factors of Salt-reduction Behavior among Residents: a Mixed Methods Research Based on the PRECEDE Model [J]. Chinese General Practice, 2024, 27(10): 1221-1230. |
[14] | ZHAO Ru, HAN Chen, HUANG Zeyu, WANG Qian, HU Jun, GE Zhijuan, BI Yan, SHEN Shanmei. Correlation of Serum Uric Acid and Serum Uric Acid/Creatinine Ratio Levels with Adverse Pregnancy Outcomes in Late Pregnancy [J]. Chinese General Practice, 2024, 27(09): 1074-1081. |
[15] | FAN Jing, WEI Shan, LI Liqiu, ZHENG Xiuli, LI Yan, NIU Jianying, WANG Ling, XU Chengyan. Investigation on the Incidence and Influencing Factors of Proteinuria and Renal Dysfunction in Community-dwelling Elderly Population [J]. Chinese General Practice, 2024, 27(09): 1048-1053. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||